Company: CGABL
Filing Date: 2025-09-17
Form Type: 424B5
Source: 0001193125-25-206326
Chunk: 3

Company: Carlyle Group Inc.
Filing Date: 2025-09-17
Form: 424B5
Chunk 3
---
, and the underwriters have not, authorized anyone to provide you with different information, and neither we nor the underwriters take responsibility for any other information that others may give you. This prospectus supplement may be used only where it is legal to sell the notes offered hereby. You should assume that the information in this prospectus supplement, the accompanying prospectus, any related free writing prospectus or any document incorporated or deemed incorporated herein by reference is accurate only as of the date on the front cover of those respective documents. Our business, financial condition, results of operations and prospects may have changed since such dates.

For
investors outside the United States: neither we nor any of the underwriters has done anything that would permit this offering or possession or distribution of this prospectus supplement, the accompanying prospectus or any free writing prospectus we
may provide to you in connection with this offering in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering
and the distribution of this prospectus supplement, the accompanying prospectus and any such free writing prospectus outside of the United States.

Unless the context suggests otherwise, references in this prospectus supplement to “Carlyle,” the “Company,”
“we,” “us” and “our” refer to The Carlyle Group Inc. and its consolidated subsidiaries. References to the “Issuer” refer to The Carlyle Group Inc.

References herein to our “senior credit facility” are to our $1 billion revolving credit facility. References to our
“Global Credit revolving credit facility” are to our revolving line of credit primarily intended to support certain lending activities within our Global Credit segment. References herein to our “CLO term loans” are to certain
term loans and other financing arrangements we have borrowed to finance a portion of our investments in certain collateralized loan obligation vehicles. References herein to our “existing notes” refer collectively to (i) the
$425 million aggregate principal amount of 3.500% Senior Notes due 2029 issued by Carlyle Finance Subsidiary L.L.C., which we refer to as the “2029 notes,” (ii) the $600.0 million aggregate principal amount of 5.625% Senior
Notes due 2043 issued by Carlyle Holdings II Finance L.L.C., which we refer to as the “2043 notes,” (iii) the $350 million aggregate principal amount of 5.650% Senior Notes due